The active oil is myristicin, about one to three percent of the seed by weight 1. The popular story is that your liver turns it into an MDMA-like amphetamine. On paper myristicin sits one step from MMDA, but that conversion has never been shown to happen in a human body 2. What actually shows up at the bedside is anticholinergic: racing heart, dry mouth, flushed skin, agitation, hallucinations — the same picture as too much diphenhydramine, plus a weak MAO inhibition and a heavy chemical load on the gut 3 4. It is a deliriant, not ecstasy. Nothing in it is a clean recreational target.
What a tablespoon buys a healthy adult, on no medications:
- Three to eight hours of nothing. You start to think it didn't work.
- Then nausea you don't get to time, and vomiting that isn't brief.
- Twelve to thirty-six hours of a heart at 110 to 140 beats a minute, a flushed face, a mouth like sandpaper, and hallucinations you cannot turn off.
- A second day of exhaustion, body aches, and lingering nausea 5 6.
The whole run is dysphoric. Across the case-series record, the word that recurs from people afterwards is regret, and the most reliable finding is that they don't try it twice 6.
The numbers that decide it:
The fine print — when to skip it, and what people get wrong
- 1Sangalli BC, Chiang W (2000). Toxicology of nutmeg abuse. Journal of Toxicology: Clinical Toxicology. link
- 2Beyer J, Ehlers D, Maurer HH (2006). Abuse of nutmeg: studies on the metabolism and the toxicokinetic of its ingredients elemicin and myristicin using rat brain microsomes. Therapeutic Drug Monitoring. link
- 3Demetriades AK, Wallman PD, McGuiness A, Gavalas MC (2005). Low cost, high risk: accidental nutmeg intoxication. Emergency Medicine Journal. link
- 4Truitt EB, Duritz G, Ebersberger EM (1963). Evidence of monoamine oxidase inhibition by myristicin and nutmeg. Proceedings of the Society for Experimental Biology and Medicine. link
- 5Stein U, Greyer H, Hentschel H (2001). Nutmeg (myristicin) poisoning—report on a fatal case and a series of cases recorded by a poison information centre. Forensic Science International. link
- 6Ehrenpreis JE, DesLauriers C, Lank P, Armstrong PK, Leikin JB (2014). Nutmeg poisonings: a retrospective review of 10 years experience from the Illinois Poison Center, 2001-2011. Journal of Medical Toxicology. link
- 7Carstairs SD, Cantrell FL (2011). The spice of life: an analysis of nutmeg exposures in California. Clinical Toxicology. link
- 8Hallstrom H, Thuvander A (1997). Toxicological evaluation of myristicin. Natural Toxins. link
- 9McKenna A, Nordt SP, Ryan J (2004). Acute nutmeg poisoning. European Journal of Emergency Medicine. link
Nutmeg and Myristicin
Four large poison-control case series across two continents and two decades (Stein et al. 2001 [Erfurt]; Forrester 2005 [Texas]; Carstairs & Cantrell 2011 [California]; Ehrenpreis et al. 2014 [Illinois]) converge on a consistent toxicity profile, threshold doses, and onset latency. RCTs are not ethically possible. Mechanism is partially worked out (anticholinergic and weak MAOI components are well documented; the popular myristicin-to-MMDA conversion claim is not yet demonstrated in vivo).